Literature DB >> 16033745

Prevalence and outcomes of childhood visual disorders.

Ursula M Donnelly1, Nuala M Stewart, Mina Hollinger.   

Abstract

PURPOSE: This population-based study examines the prevalence of childhood visual disorders: amblyopia (strabismus, refractive errors) and organic disease. It also assesses treatment outcomes, visual impairment and residual amblyopia.
METHODS: 1582 children were retrospectively analysed on treatment completion (age 8-9 years). Significant visual disorders included: esotropia, exotropia, anisometropia (hyperopia > or = 1.50DS, astigmatism > or = 1.00DC, myopia > or = 1.50DS), ametropia (hyperopia > or = 1.50DS, astigmatism > or = 1.0DC, myopia > or = 0.75DS) and organic defects.
RESULTS: 198 children (12.5%) had a significant visual disorder: strabismus (3.98%), eso:exo rate 5:1, anisometropia (2.34%), ametropia (5.82%), organic defects (0.38%). Organic disease caused visual handicap (< 6/18 in better eye) in 0.13%. Amblyopic visual impairment (6/18; 6/24-6/60) occurred in 1.13%; 2.02% had residual amblyopia (6/12 or worse).
CONCLUSIONS: Childhood visual disorders are a common problem. Unfavourable visual outcomes in esotropia are related to two sub-groups and particularly with poor concordance to treatment. Suggested strategies to improve outcomes include health promotion, an "Amblyopia Nurse" and a "Patch Club".

Entities:  

Mesh:

Year:  2005        PMID: 16033745     DOI: 10.1080/09286580590967772

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  29 in total

1.  Prevalence of strabismus among preschool, kindergarten, and first-grade Tohono O'odham children.

Authors:  Katherine A Garvey; Velma Dobson; Dawn H Messer; Joseph M Miller; Erin M Harvey
Journal:  Optometry       Date:  2010-04

2.  The burden of pure anisometropic amblyopia: a cross-sectional study on 2800 Iranians.

Authors:  Siamak Akbarzadeh; Reihaneh Vahabi; Nooshin Bazzazi; Ghodratollah Roshanaei; Samira Heydarian; Daniel F Fouladi
Journal:  Int Ophthalmol       Date:  2017-12-13       Impact factor: 2.031

3.  Prevalence of amblyopia and strabismus in young singaporean chinese children.

Authors:  Audrey Chia; Mohamed Dirani; Yiong-Huak Chan; Gus Gazzard; Kah-Guan Au Eong; Prabakaran Selvaraj; Yvonne Ling; Boon-Long Quah; Terri L Young; Paul Mitchell; Rohit Varma; Tien-Yin Wong; Seang-Mei Saw
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-05       Impact factor: 4.799

4.  Candidate gene and locus analysis of myopia.

Authors:  Donald O Mutti; Margaret E Cooper; Sarah O'Brien; Lisa A Jones; Mary L Marazita; Jeffrey C Murray; Karla Zadnik
Journal:  Mol Vis       Date:  2007-06-28       Impact factor: 2.367

5.  Outcome of monocular surgery for horizontal strabismus in Hyderabad.

Authors:  Sameen A Junejo; Munawar A Ansari
Journal:  Clin Ophthalmol       Date:  2010-04-26

Review 6.  Amblyopia and binocular vision.

Authors:  Eileen E Birch
Journal:  Prog Retin Eye Res       Date:  2012-11-29       Impact factor: 21.198

Review 7.  The relationship between anisometropia and amblyopia.

Authors:  Brendan T Barrett; Arthur Bradley; T Rowan Candy
Journal:  Prog Retin Eye Res       Date:  2013-06-15       Impact factor: 21.198

8.  Associations between anisometropia, amblyopia, and reduced stereoacuity in a school-aged population with a high prevalence of astigmatism.

Authors:  Velma Dobson; Joseph M Miller; Candice E Clifford-Donaldson; Erin M Harvey
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-06       Impact factor: 4.799

9.  Does assessing eye alignment along with refractive error or visual acuity increase sensitivity for detection of strabismus in preschool vision screening?

Authors: 
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-07       Impact factor: 4.799

10.  Anisometropia prevalence in a highly astigmatic school-aged population.

Authors:  Velma Dobson; Erin M Harvey; Joseph M Miller; Candice E Clifford-Donaldson
Journal:  Optom Vis Sci       Date:  2008-07       Impact factor: 1.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.